CORONA REMEDIES LIMITED (CORONA)

NSE: ₹1,701.30
BSE: ₹1,701.95
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 361.13 342.42 353.09
YOY Revenue Growth % - - -
Other Income 2.27 2.24 4.11
Total Income 363.40 344.66 357.20
Total Expenses + 293.79 270.37 302.74
Cost of Materials Consumed 25.90 24.82 27.73
Employee Benefit Expense 103.00 95.94 106.63
Other Expenses 111.01 103.05 118.20
Operating Profit 67.34 72.05 50.35
OPM % 18.6% 21% 14.3%
Profit Before Tax + 69.61 55.21 54.74
Tax Expense 17.29 13.94 9.41
Tax % 24.8% 25.2% 17.2%
Profit After Tax 52.32 41.27 45.33
EPS (Basic) 8.55 6.75 7.41

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 1,403.18
YOY Revenue Growth % -
Other Income 10.65
Total Income 1,413.83
Total Expenses + 1,154.58
Cost of Materials Consumed 103.51
Employee Benefit Expense 403.02
Other Expenses 445.78
Operating Profit 248.60
OPM % 17.7%
Profit Before Exceptional 259.25
Exceptional Items -18.83
Profit Before Tax + 240.42
Tax Expense 55.30
Tax % 23%
Profit After Tax 185.12
EPS (Basic) 30.27

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 856.83
Property, Plant & Equipment 291.14
Capital Work in Progress 143.12
Non-Current Investments 0.17
Goodwill 0.00
Other Intangible Assets 262.83
Current Assets + 348.31
Inventories 125.00
Trade Receivables 145.55
Cash and Cash Equivalents 1.83
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 746.86
Equity Share Capital 61.16
Other Equity 685.70
Non-Current Liabilities 97.11
Current Liabilities 361.17
Total Liabilities 458.28

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 229.48
Cash from Investing Activities -256.15
Cash from Financing Activities 25.28
Net Increase/Decrease in Cash -1.39